DocGo Inc. Granted Nasdaq Extension; Reverse Stock Split Authorized

What Happened
DocGo Inc. (DCGO) filed an 8-K reporting that the Nasdaq Listing Qualifications Department granted the company an additional 180 calendar days — until January 25, 2027 — to regain compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). Nasdaq will confirm compliance if DocGo’s closing bid price is at least $1.00 per share for 10 consecutive business days before that deadline. The company signed the filing on July 30, 2026.

At its June 16, 2026 annual meeting, DocGo’s stockholders approved an amendment allowing the board to implement a reverse stock split at a ratio of 1-for-5, 1-for-6, 1-for-7, 1-for-8, 1-for-9 or 1-for-10, to be determined by the board. The company said it will monitor the closing bid price and evaluate options to regain compliance, including potentially effecting a reverse split.

Key Details

• Nasdaq granted a 180-day compliance extension, deadline: January 25, 2027.
• Compliance condition: closing bid ≥ $1.00 per share for at least 10 consecutive business days.
• Stockholders authorized a reverse split range of 1-for-5 through 1-for-10 (approved June 16, 2026).
• 8-K signed by Norman Rosenberg, CFO, on July 30, 2026.

Why It Matters
This filing signals that DocGo is currently below Nasdaq’s minimum bid-price standard and has limited time to restore compliance. A reverse stock split is a commonly used tool to increase per‑share market price and meet listing requirements, but it reduces the number of outstanding shares and can affect liquidity and per‑share metrics. If DocGo does not meet the $1.00 threshold by the January 25, 2027 deadline, it could face delisting proceedings, which would be a material event for shareholders.